Matthias Tschöp

Prof. Matthias Tschöp is a Professor of Metabolic Diseases at the Technical University of Munich (TUM) since 2011 and Scientific Director/Spokesperson of the Management Board at Helmholtz Zentrum München since 2018. He holds the Alexander von Humboldt Professorship (2012) and is a member of the German National Academy of Sciences Leopoldina since 2013. His research focuses on the molecular mechanisms underlying diabetes and obesity, particularly gut-brain communication and its role in glucose and energy metabolism regulation. He leads interdisciplinary efforts at the Institute of Diabetes and Obesity (IDO) to develop personalized therapies for metabolic diseases.

• Educations:
  • Studied and obtained his doctorate at Ludwig Maximilian University, Munich
  • Postdoctoral positions at Eli Lilly and the German Institute of Human Nutrition (Potsdam)

His research interests include innovative therapeutic approaches for metabolic comorbidities. Key publications highlight breakthroughs in hormonal therapies, cholesterol regulation via melanocortin signaling, and ghrelin's role in obesity pathogenesis. Awards include the Paul Langerhans Medal (2019), Hansen Family Prize (2017), and Erwin Schrödinger Prize (2014).

• Labs/Teams: Leads the Institute of Diabetes and Obesity (IDO) at Helmholtz Zentrum München, focusing on translational research in metabolic diseases.